HomeVenture Capital

Venture Capital

Venture Capital

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

Life Sciences Times - 0
Venture Capital

Canid Raises $10 Million to Modernize Pediatric Vaccine Management and Reduce Burden on Independent Practices

Life Sciences Times - 0
Venture Capital

Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule

Life Sciences Times - 0
Venture Capital

KalVista Pharmaceuticals Awards Stock Options to New Employees Under Nasdaq Rule

Life Sciences Times - 0
Venture Capital

Bruker Acquires biocrates to Expand Multiomics Capabilities in Metabolomics and Lipidomics

Life Sciences Times - 0
Venture Capital

Agenus and Zydus Lifesciences Sign $141 Million Deal to Advance Cancer Immunotherapy and Expand U.S. Biologics Manufacturing

Life Sciences Times - 0
Venture Capital

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

Life Sciences Times - 0
Venture Capital

Outcomes4Me Raises $21 Million to Advance AI-Powered Cancer Care and Expand Globally

Life Sciences Times - 0
Venture Capital

Vivodyne Raises $40 Million to Replace Animal Testing with AI-Powered Human Tissue Models

Life Sciences Times - 0
Venture Capital

GlycoEra Raises $130 Million to Advance Autoimmune Disease Treatment Pipeline

Life Sciences Times - 0
Venture Capital

bluebird bio Urges Stockholders to Tender Shares Ahead of May 29 Deadline for Carlyle and SK Capital Acquisition

Life Sciences Times - 0
Venture Capital

KindlyMD Changes NASDAQ Ticker to ‘NAKA’ as It Aligns with Bitcoin-Focused Merger

Life Sciences Times - 0
1...141516...115Page 15 of 115

Most Read